Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-103641
Filing Date
2022-09-28
Accepted
2022-09-28 14:02:38
Documents
4
Period of Report
2022-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2225744d2_6k.htm 6-K 10456
2 EXHIBIT 99.1 tm2225744d2_ex99-1.htm EX-99.1 15433
3 GRAPHIC tm2225744d2_ex99-1img01.jpg GRAPHIC 3829
4 GRAPHIC tm2225744d2_ex99-1img02.jpg GRAPHIC 60173
  Complete submission text file 0001104659-22-103641.txt   115402
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 221274919
SIC: 2833 Medicinal Chemicals & Botanical Products